We invite you to attend the 4th Immunogenicity & Immunotoxicity Conference, which will take place on January 25-26, 2016 in San Diego, CA.
GTCbio is proud to announce its 4th Immunogenicity & Immunotoxicity Conference, one of three parallel tracks to the Novel Immunotherapeutics Summit 2016 on January 25-26, 2016 in San Diego, CA. The conference will cover important progress made in the areas of therapeutic protein immunogenicity and immunotoxicity evaluation such as protein aggregation, clinical relevance and assessment of immunogenicity, mitigation of immunogenicity-related risks, biosimilar development, and immunotoxicity evaluation strategies. The Immunogenicity and Immunotoxicity Conference will provide guests with a better understanding of the ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.
Organization: GTCbio (https://www.gtcbio.com/)
For more information, please visit: https://www.gtcbio.com/
January 25-26, 2016
Paradise Point Resort & Spa
1404 Vacation Road San Diego, CA 92109, San Diego, United States
Contact: Kristen Starkey (infogtcbio@gtcbio.com)
Phone: 626-256-6405
